Press release
Neuroendocrine Tumor Treatment Market: Exploring Market Size, CAGR, Drivers, and Trends
Neuroendocrine Tumor Treatment Market Share
What Is The Projected Market Size Of The Global Neuroendocrine Tumor Treatment Market And Its Growth Rate?
The neuroendocrine tumor treatment market has been experiencing significant growth in the recent years.
• It will rise from $2.17 billion in 2024 to $2.4 billion in 2025 at a CAGR of 10.6%.
• This growth can be largely credited to clinical research, medical expertise, and advancements in radiation therapy, among others.
• Expected to further soar to $3.6 billion in 2029 at a CAGR of 10.7%, the market is being propelled by innovations in precision medicine, immunotherapy, and minimally invasive procedures.
What Is Driving The Growth In The Neuroendocrine Tumor Treatment Market?
The increase in cases of neuroendocrine tumors (NETs) are fueling the advancement of the neuroendocrine tumor treatment market. NETs, a rare type of tumor that originates from neuroendocrine cells, are managed through neuroendocrine tumor treatment to control symptoms, tumor growth, and to kill tumor cells with radiation therapy. Recent statistics indicate that over 12,000 people are diagnosed with NETs annually in the US, while Australia recorded 5,437 cases in 2022. Hence, the growing prevalence of neuroendocrine tumors is influencing the growth of the neuroendocrine tumor treatment market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12248&type=smp
Who Are the Key Players Driving Neuroendocrine Tumor Treatment Market Growth?
The neuroendocrine tumor treatment market is backed by numerous prominent companies, including:
• Pfizer Inc.
• F Hoffmann-La Roche AG
• AbbVie Inc.
• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca
• Takeda Pharmaceutical
• Eli Lilly And Company
• Amgen Inc.
What Are The Key Trends In The Neuroendocrine Tumor Treatment Market?
The neuroendocrine tumor treatment market is witnessing several trends, such as:
• Advancements in diagnostic technologies
• Progress in peptide receptor radionuclide therapy (PRRT)
• Usage of nanotechnology in drug delivery
• Emergence of radiopharmaceuticals
• Cross disciplinary collaboration
What Are The Segments Of The Global Neuroendocrine Tumor Treatment Market?
The neuroendocrine tumor treatment market is segmented by:
1) Product: Somatostatin Analogs (SSAs), Targeted Therapy, Chemotherapy, Others
2) Indication: Lungs, Pancreas, Gastrointestinal, Others
3) End-Users: Hospitals, Oncology Centers, Other End-Users
Which Region Leads The Neuroendocrine Tumor Treatment Market?
North America stands as the largest region in the neuroendocrine tumor treatment market in 2024. The other regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/neuroendocrine-tumor-treatment-global-market-report
What Is Covered In The Neuroendocrine Tumor Treatment Market Global Market Report?
•Market Size Analysis
•Market Segmentation Analysis
•Key Player Focus
•Growth Trends Analysis
•Market Contribution
•Growth Drivers
•Industry Challenges
•Competitive Developments.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12248&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Tumor Treatment Market: Exploring Market Size, CAGR, Drivers, and Trends here
News-ID: 3833689 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neuroendocrine
Neuroendocrine Carcinoma Market Massive Growth opportunity Ahead
Introduction
Neuroendocrine carcinoma (NEC) is a rare and aggressive form of cancer that arises from neuroendocrine cells, which are found throughout the body and are responsible for producing hormones. These tumors can occur in various organs, including the lungs, pancreas, liver, and gastrointestinal tract. Due to its often vague and non-specific symptoms, neuroendocrine carcinoma is frequently diagnosed at an advanced stage, making it challenging to treat effectively.
In recent years, however, there…
Rising Neuroendocrine Tumors Fuel Treatment Market Growth Driving Market Acceler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuroendocrine Tumor Treatment Market Size By 2025?
The industry for treating neuroendocrine tumors has witnessed substantial growth in the previous years. The market size is projected to escalate from $2.17 billion in 2024 to $2.4 billion in 2025, with a compound annual growth rate (CAGR)…
Emerging Trends Influencing The Growth Of The Neuroendocrine Tumor Treatment Mar …
The Neuroendocrine Tumor Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Neuroendocrine Tumor Treatment Market Size Expected to Be by 2034?
The market for neuroendocrine tumor treatment has seen a significant expansion in recent years. Projected to grow from a value…
Prominent Neuroendocrine Tumor Treatment Market Trend for 2025: Clinical Trials …
How Are the key drivers contributing to the expansion of the neuroendocrine tumor treatment market?
The neuroendocrine tumor treatment market is forecasted to expand due to the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors, or NETs, are rare growths that begin in neuroendocrine cells, and their treatment is vital to managing the symptoms, controlling the tumor's growth, and applying radiation therapy to destroy the cancerous cells. The American Society of Clinical…
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Gro …
The market report titled ‘Global Neuroendocrine Cancer Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of…
